Floatz logo

CYCLOSPORIN A

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome

Case Comprehensive Cancer Centerprotein_peptidePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
81/ 100

Competitive context

36 Active assets in the Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
National Cancer Institute (NCI)
Phase 3BB
ETOPOSIDE
Institut de Recherches Internationales Servier
Phase 2BB
Daunorubicin
Institut de Recherches Internationales Servier
Phase 3BB
Decitabine
National Cancer Institute (NCI)
Phase 3BB
Cyclophosphamide
City of Hope Medical Center
Phase 3BB

View all 50 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →